Advertisement
Screener

Altamira Therapeutics Ltd. (CYTOF) Form 6-K: Report of foreign private issuer, 2016

Altamira Therapeutics Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2016-12-06: Form 6-K; Period of report 2016-12-06; Description FORM 6-K; Document dp70956_6k.htm.
  • 2016-11-10: Form 6-K; Period of report 2016-11-10; Description FORM 6-K; Document dp70129_6k.htm.
  • 2016-10-11: Form 6-K; Period of report 2016-10-11; Description FORM 6-K; Document dp69382_6k.htm.
  • 2016-09-19: Form 6-K; Period of report 2016-09-19; Description FORM 6-K; Document dp68760_6k.htm.
FiledFormPeriod of reportDescriptionDocument
2016-12-066-K2016-12-06FORM 6-Kdp70956_6k.htm
2016-11-106-K2016-11-10FORM 6-Kdp70129_6k.htm
2016-10-116-K2016-10-11FORM 6-Kdp69382_6k.htm
2016-09-196-K2016-09-19FORM 6-Kdp68760_6k.htm
2016-08-186-K2016-08-18FORM 6-Kdp67954_6k.htm
2016-07-196-K2016-07-19FORM 6-Kdp67255_6k.htm
2016-06-016-K2016-06-01FORM 6-Kdp66070_6k.htm
2016-05-116-K2016-05-11FORM 6-Kdp65578_6k.htm
2016-04-116-K2016-04-11FORM 6-Kdp64873_6k-articles.htm
2016-04-086-K2016-04-08FORM 6-Kdp64872_6k-agm.htm
2016-03-146-K2016-03-14FORM 6-Kdp64099_6k.htm